BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

A R Lingford-Hughes, S Welch, L Peters, D J Nutt, British Association for Psychopharmacology, Expert Reviewers Group, Marcus R Munafo

Research output: Contribution to journalArticle (Academic Journal)peer-review

158 Citations (Scopus)

Abstract

The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.
Original languageEnglish
Pages (from-to)899-952
Number of pages54
JournalJournal of Psychopharmacology
Volume26
Issue number7
DOIs
Publication statusPublished - Jul 2012

Structured keywords

  • Brain and Behaviour
  • Tobacco and Alcohol

Keywords

  • Evidence-Based Medicine
  • Substance Withdrawal Syndrome
  • Pregnancy Complications
  • Combined Modality Therapy
  • Humans
  • Aged
  • Child
  • Comorbidity
  • Great Britain
  • Pregnancy
  • Psychotherapy
  • Mental Disorders
  • Adult
  • Substance-Related Disorders
  • Adolescent
  • Diagnostic and Statistical Manual of Mental Disorders
  • Female
  • Male

Fingerprint Dive into the research topics of 'BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP'. Together they form a unique fingerprint.

Cite this